CHAITANYA R DIVGI, MD
Medical Practice at 168 St, New York, NY
License number
New York 185493
Category
Medical Practice
Type
Nuclear Medicine
Address
Address
722 W 168Th St, New York, NY 10032
Phone
(212) 305-5521
(212) 304-5277 (Fax)
(212) 304-5277 (Fax)
Personal information
See more information about CHAITANYA R DIVGI at radaris.comName
Address
Phone
455 Central Park W, New York, NY 10025
401 89Th St, New York, NY 10128
401 89Th St, New York, NY 10128
Organization information
See more information about CHAITANYA R DIVGI at bizstanding.comNew York Presbyterian Hospital - Chaitanya R Divgi MD
177 Ft Washington Ave, New York, NY 10032
Categories:
Physicians & Surgeons
Phone:
(212) 305-3669 (Phone)
Professional information
Dr. Chaitanya R Divgi, New York NY - MD (Doctor of Medicine)
Specialties:
Nuclear Medicine
Address:
722 W 168Th St, New York 10032
(212) 305-5521 (Phone), (212) 304-5277 (Fax)
University Pennsylvania Abramson Cancer Center
3400 Spruce St SUITE 16, Philadelphia 19104
(800) 789-7366 (Phone)
(212) 305-5521 (Phone), (212) 304-5277 (Fax)
University Pennsylvania Abramson Cancer Center
3400 Spruce St SUITE 16, Philadelphia 19104
(800) 789-7366 (Phone)
Certifications:
Nuclear Medicine, 1988
Awards:
Healthgrades Honor Roll
Languages:
English
Education:
Medical School
Bangalore Medical College, Rajiv Gandhi University Of Health Sciences
Graduated: 1976
St Marthas Hospital
Jaslok Hospital
Graduated: 1981
Meml Hosp/sloan Kettering
Graduated: 1987
Meml Sloan Kettering
Graduated: 1988
Bangalore Medical College, Rajiv Gandhi University Of Health Sciences
Graduated: 1976
St Marthas Hospital
Jaslok Hospital
Graduated: 1981
Meml Hosp/sloan Kettering
Graduated: 1987
Meml Sloan Kettering
Graduated: 1988
Chaitanya R Divgi, New York NY
Specialties:
Nuclear Medicine Specialist
Address:
1275 York Ave, New York, NY 10065
Education:
St. John's Medical College - Bachelor of Medicine, Bachelor of Surgery
Doctor of Medicine
Memorial Sloan-Kettering Cancer Center - Fellowship - Immunology
Memorial Sloan-Kettering Cancer Center - Residency - Nuclear Medicine
St. Martha's Hospital - Bangalore - Internship - Rotating
Doctor of Medicine
Memorial Sloan-Kettering Cancer Center - Fellowship - Immunology
Memorial Sloan-Kettering Cancer Center - Residency - Nuclear Medicine
St. Martha's Hospital - Bangalore - Internship - Rotating
Board certifications:
American Board of Nuclear Medicine Certification in Nuclear Medicine
Method Of Treating Colorectal Carcinoma Lesion And Composition For Use Therein
US Patent:
5643550, Jul 1, 1997
Filed:
Sep 27, 1994
Appl. No.:
8/312633
Inventors:
Sydney Welt - New York NY
Chaitanya R. Divgi - New York NY
Samual Yeh - New York NY
Lloyd J. Old - New York NY
Herbert F. Oettgen - New Canaan CT
Francisco X. Real - Barcelona, ES
Junichi Sakamoto - Chikusaku Nagoya, JP
Chaitanya R. Divgi - New York NY
Samual Yeh - New York NY
Lloyd J. Old - New York NY
Herbert F. Oettgen - New Canaan CT
Francisco X. Real - Barcelona, ES
Junichi Sakamoto - Chikusaku Nagoya, JP
Assignee:
Sloan-Kettering Institute for Cancer Research - New York NY
International Classification:
A61K 5100, A61K 4900, A61K 3514
US Classification:
424 185
Abstract:
This invention provides a method of imaging a colorectal carcinoma lesion in a human patient which comprises administering to the patient a monoclonal antibody capable of binding to a cell surface antigen associated with the colorectal carcinoma lesion and which is labeled with an imaging agent under conditions so as to form a complex between the monoclonal antibody and the cell surface antigen, imaging any complex so formed, and thereby imaging the colorectal carcinoma lesion.
This invention also provides a monoclonal antibody designated AS 33 (ATCC Accession No. HB 8779) and the hybridoma which produces it.
Method Of Imaging Colorectal Carcinoma Lesion And Composition For Use Therein
US Patent:
5431897, Jul 11, 1995
Filed:
Feb 16, 1993
Appl. No.:
8/020223
Inventors:
Sydney Welt - New York NY
Chaitanya R. Divgi - New York NY
Samual Yeh - New York NY
Lloyd J. Old - New York NY
Herbert F. Oettgen - New Canaan CT
Francisco X. Real - Barcelona, ES
Junichi Sakamoto - Chikusaku Nagoya, JP
Chaitanya R. Divgi - New York NY
Samual Yeh - New York NY
Lloyd J. Old - New York NY
Herbert F. Oettgen - New Canaan CT
Francisco X. Real - Barcelona, ES
Junichi Sakamoto - Chikusaku Nagoya, JP
Assignee:
Sloan-Kettering Institute for Cancer Research - New York NY
International Classification:
A61K 4300, A61K 4900, A61K 3514, G01N 33566
US Classification:
424 149
Abstract:
This invention provides a method of imaging a colorectal carcinoma lesion in a human patient which comprises administering to the patient a monoclonal antibody capable of binding to a cell surface antigen associated with the colorectal carcinoma lesion and which is labeled with an imaging agent under conditions so as to form a complex between the monoclonal antibody and the cell surface antigen, imaging any complex so formed, and thereby imaging the colorectal carcinoma lesion.
This invention also provides a monoclonal antibody designated AS 33 (ATCC Accession No. HB 8779) and the hybridoma which produces it.
Method Of Imaging Colorectal Carcinoma Lesion And Composition For Use Therein
US Patent:
5160723, Nov 3, 1992
Filed:
Mar 18, 1991
Appl. No.:
7/671132
Inventors:
Sydney Welt - New York NY
Chaitanya R. Divgi - New York NY
Samual Yeh - New York NY
Lloyd J. Old - New York NY
Herbert F. Oettgen - New Canaan CT
Francisco X. Real - Barcelona, ES
Junichi Sakamoto - Chikusaku Nagoya, JP
Chaitanya R. Divgi - New York NY
Samual Yeh - New York NY
Lloyd J. Old - New York NY
Herbert F. Oettgen - New Canaan CT
Francisco X. Real - Barcelona, ES
Junichi Sakamoto - Chikusaku Nagoya, JP
Assignee:
Sloan-Kettering Institute For Cancer Research - New York NY
International Classification:
A61K 4902, C07K 1528, C07K 1500
US Classification:
424 11
Abstract:
This invention provides a method of imaging a colorectal carcinoma lesion in a human patient which comprises administering to the patient a monoclonal antibody capable of binding to a cell surface antigen associated with the coloretal carcinoma lesion and which is labeled with an imaging agent under conditions so as to form a complex between the monoclonal antibody and the cell surface antigen, imaging any complex so formed, and thereby imaging the colorectal carcinoma lesion.
This invention also provides a monoclonal antibody designated AS 33 (ATCC Accession No. HB 8779) and the hybridoma which produces it.
Hybridoma Cell Lines Which Produce Monoclonal Antibodies Having The Properties Of Monoclonal Antibody 100-310 And The Monoclonal Antibodies Produced By These Hybridoma Cell Lines
US Patent:
5565356, Oct 15, 1996
Filed:
Jul 11, 1994
Appl. No.:
8/273277
Inventors:
Sydney Welt - Armonk NY
Clarence Williams - Riverdale NY
Elsje C. Barendswaard - New York NY
Chaitanya R. Divgi - New York NY
Lloyd J. Old - New York NY
Clarence Williams - Riverdale NY
Elsje C. Barendswaard - New York NY
Chaitanya R. Divgi - New York NY
Lloyd J. Old - New York NY
Assignee:
Memorial Sloan-Kettering Cancer Center - New York NY
International Classification:
C12N 520, C07K 1630
US Classification:
43524027
Abstract:
Monoclonal antibody 100-310 is found to be reactive against colon cancer cells and would therefore be useful for diagnostic imaging and treatment of colon cancer.